Antibody-Drug Conjugate to Treat Cancer - BOC Sciences

0 0 hace 10 meses
Antibody-drug conjugates (ADCs) are a very important class of highly potent drugs designed as a targeted therapy for the treatment of people who has cancer. BOC Sciences is the industry leading expert in small molecular and antibody engineering, also our rich experience could help us to provide comprehensive services for the conjugation and characterization of Antibody-Drug Conjugates.

Síguenos en Facebook

Copyright 2019 - Spreaker Inc. a Voxnest Company - Crea un podcast - New York, NY